why choose us

First received: April 25, 2023

Clinical Trial: Supplemental Citicoline Administration to Reduce Lung Injury Efficacy Trial (SCARLET)

Study Status: Completed

Recruit Status: RECRUITING

Condition: COVID-19

Study Type: INTERVENTIONAL


Official Title: Supplemental Citicoline Administration to Reduce Lung Injury Efficacy Trial (SCARLET)

Brief Summary: The goal of this single center, double-blinded, placebo-controlled, and randomized Phase 1 trial is to determine if i.v.citicoline is safe and efficacious compared to i.v.saline/control in adults presenting with SARS CoV-2 infection complicated by acute hypoxemic respiratory failure.The main questions it aims to answer:Is citicoline safe in this patient population?Does citicoline have a benefit in terms of improving oxygenation?Does citicoline reduce overall severity of illness as reflected by standardized…

Read more